Regulatory Show all
September 29 | 2022

2cureX terminates liquidity provision service

Read more
September 19 | 2022

Change of distribution partner in Portugal

Read more
September 1 | 2022

2cureX expands distribution of IndiTreat® to Romania

Read more
August 25 | 2022

2cureX publishes interim report for the second quarter and first half of 2022

Read more
August 25 | 2022

2cureX offentliggör delårsrapport för det andra kvartalet och första halvåret 2022

Read more
August 22 | 2022

Invitation to 2cureX Webcast on August 25, 2022.

Read more
August 8 | 2022

Announcement from 2cureX extra general meeting

Read more
August 8 | 2022

Kommuniké från extra bolagsstämma i 2cureX

Read more
July 20 | 2022

Notice of extra general meeting in 2cureX AB

Read more
July 20 | 2022

Kallelse till extra bolagsstämma i 2curex AB

Read more
July 1 | 2022

Dr. Raphael Gruber joins 2cureX as new Medical Director

Read more
June 28 | 2022

2cureX expands distribution of IndiTreat® to Israel

Read more
June 7 | 2022

2cureX AB announces share purchase by the company’s Chairman of the Board of Directors and Executive Management

Read more
May 31 | 2022

Strengthening the IndiTreat® distribution in North Europe

Read more
May 24 | 2022

Kommuniké från årsstämma i 2cureX AB

Read more
May 24 | 2022

2cureX publishes interim report for the first quarter 2022

Read more
May 24 | 2022

2cureX offentliggör delårsrapport för det första kvartalet 2022

Read more
May 20 | 2022

We invite you to join the 2cureX Q1 Report webcast and Q&A session at 15:00 on 24 May, 2022

Read more